Loading
Latest filing published 15 May 2026 for Viscom SE, €4,910. Read the official filing
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Dr. Martin Heuser is a declared insider of Viscom SE, with filings sourced from BaFin. We count 6 filings; the first trade dates from 12 May 2026 and the latest from 13 May 2026.
The open-market record is one-sided, with 6 purchases worth €78k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
In size, the median ticket on the buying side is €14k. Scaled by market value, the purchases weigh a median 0.026% of market cap (sample: 6 purchases). No cluster: in 5 purchases, no other insider of the company bought within 30 days. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +19.8%. This is a record of the past, not a forecast.
On 15 May 2026 came the latest disclosure, an open-market purchase for €4,910 in Viscom SE. The median gap between a trade and its publication by BaFin is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by BaFin and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations